Fosamprenavir
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 45 (2) , 137-168
- https://doi.org/10.2165/00003088-200645020-00002
Abstract
Fosamprenavir is one of the most recently approved HIV-1 protease inhibitors (Pis) and offers reductions in pill number and pill size, and omits the need for food and fluid requirements associated...Keywords
This publication has 61 references indexed in Scilit:
- Ritonavir Increases Plasma Amprenavir (APV) Exposure to a Similar Extent when Coadministered with either Fosamprenavir or APVAntimicrobial Agents and Chemotherapy, 2006
- Effect of Antacids and Ranitidine on the Single-Dose Pharmacokinetics of FosamprenavirAntimicrobial Agents and Chemotherapy, 2005
- Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2004
- A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adultsHIV Medicine, 2004
- Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected PatientsAntimicrobial Agents and Chemotherapy, 2004
- Effects of Formulation and Dosing Strategy on Amprenavir Concentrations in the Seminal Plasma of Human Immunodeficiency Virus Type 1–Infected MenClinical Infectious Diseases, 2002
- The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850)The Journal of Infectious Diseases, 2002
- Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell lineJournal of Pharmaceutical Sciences, 2001
- TheEx Vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavirInfectious Diseases in Obstetrics and Gynecology, 1998
- Effervescent and standard formulations of ranitidine—a comparison of their pharmacokinetics and pharmacologyAlimentary Pharmacology & Therapeutics, 1996